KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 121 days ( 6.96 % )
Last Price $6.55 0 %
High/ Low $6.55 - $6.55 0%
Chg 7 Days N/A $6.55 $6.55
Chg 30 Days N/A $6.55 $6.55
Chg 12 mos -34.76 % $10.04 $6.55
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -28.89 % Width: 170.32 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $2.23 - $6.04 -65.91 % - -7.84 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Feb 28, 2022 - 119 days
Long MA avg 12 mos Sell Jun 29, 2022 - 35 days
Short/Long MA avg 12 mos Sell Jun 29, 2022 - 35 days
Pivot Short Buy Aug 16, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About NantKwest

NantKwest NantKwest, Inc., a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials f... NK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT